Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): A randomized, controlled clinical process study

European Heart Journal

Volumn 36, Issue 6, 2015, Pages 369-376

  Möckel, Martin ^a   Searle, Julia ^a   Hamm, Christian ^b,c   Slagman, Anna ^a   Blankenberg, Stefan ^d   Huber, Kurt ^e   Katus, Hugo ^f   Liebetrau, Christoph ^b,c   Müller, Christian ^g   Muller, Reinhold ^h   Peitsmeyer, Philipp ^d   Von Recum, Johannes ^a   Tajsic, Milos ^e   Vollert, Jörn O ⁱ   Giannitsis, Evangelos ^f  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Kerckhoff Heart and Thorax Center   (Germany)

^c UNIVERSITY HOSPITAL GIESSEN   (Germany)

^d UNIVERSITY HEART CENTER HAMBURG   (Germany)

^e WILHELMINEN HOSPITAL   (Austria)

^f UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^g UNIVERSITY HOSPITAL BASEL   (Switzerland)

^h JAMES COOK UNIVERSITY   (Australia)

ⁱ THERMO FISHER SCIENTIFIC   (Germany)

Author keywords

Acute coronary syndrome (ACS); Acute myocardial infarction (AMI); Copeptin; Randomized controlled trial (RCT); Rule out

Indexed keywords

BIOLOGICAL MARKER; COPEPTIN; TROPONIN; GLYCOPEPTIDE; TROPONIN T;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; ARTICLE; CLINICAL ASSESSMENT; CORONARY ARTERY BYPASS GRAFT; DEATH; DIAGNOSTIC PROCEDURE; FEMALE; HEART ARRHYTHMIA; HOSPITAL DISCHARGE; HOSPITAL READMISSION; HUMAN; INTENTION TO TREAT ANALYSIS; INTERMEDIATE RISK PATIENT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SUDDEN CARDIAC DEATH; CLINICAL TRIAL; CONTROLLED STUDY; DEATH, SUDDEN, CARDIAC; EARLY DIAGNOSIS; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ACUTE CORONARY SYNDROME; ARRHYTHMIAS, CARDIAC; BIOMARKERS; CORONARY ARTERY BYPASS; DEATH, SUDDEN, CARDIAC; EARLY DIAGNOSIS; FEMALE; GLYCOPEPTIDES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT DISCHARGE; PATIENT READMISSION; PERCUTANEOUS CORONARY INTERVENTION; TREATMENT OUTCOME; TROPONIN T;

EID: 84925480988     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehu178     Document Type: Article

References (28)

1. Mockel M, Searle J, Muller R, Slagman A, Storchmann H, Oestereich P, WyrwichW, Ale-Abaei A, Vollert JO, Koch M, Somasundaram R. Chief complaints in medical emergencies: do they relate to underlying disease and outcome? The Charite Emergency Medicine Study (CHARITEM). Eur J Emerg Med 2013;20:103-108.
2. Goodacre S, Nicholl J, Dixon S, Cross E, Angelini K, Arnold J, Revill S, Locker T, Capewell SJ, Quinney D, Campbell S, Morris F. Randomised controlled trial and economic evaluation of a chest pain observation unit compared with routine care. BMJ 2004;328:254.
3. Pope JH, Aufderheide TP, Ruthazer R, Woolard RH, Feldman JA, Beshansky JR, Griffith JL, Selker HP. Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med 2000;342:1163-1170.
4. Morgenthaler NG, Struck J, Alonso C, Bergmann A. Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin. Clin Chem 2006;52:112-119.
5. Keller T, Tzikas S, Zeller T, Czyz E, Lillpopp L, Ojeda FM, Roth A, Bickel C, Baldus S, Sinning CR, Wild PS, Lubos E, Peetz D, Kunde J, Hartmann O, Bergmann A, Post F, Lackner KJ, Genth-Zotz S, Nicaud V, Tiret L, Munzel TF, Blankenberg S. Copeptin improves early diagnosis of acute myocardial infarction. J Am Coll Cardiol 2010;55: 2096-2106.
6. GuYL, VoorsAA, Zijlstra F, Hillege HL, Struck J, Masson S, VagoT, Anker SD, van den Heuvel AF, van Veldhuisen DJ, de Smet BJ. Comparison of the temporal release pattern of copeptin with conventional biomarkers in acute myocardial infarction. Clin Res Cardiol 2011;100:1069-1076.
7. Reichlin T, Hochholzer W, Stelzig C, Laule K, Freidank H, Morgenthaler NG, Bergmann A, Potocki M, Noveanu M, Breidthardt T, Christ A, Boldanova T, Merki R, Schaub N, Bingisser R, Christ M, Mueller C. Incremental value of copeptin for rapid rule out of acute myocardial infarction. J Am Coll Cardiol 2009;54:60-68.
8. Maisel A, Mueller C, Neath SX, Christenson RH, Morgenthaler NG, McCord J, Nowak RM, Vilke G, Daniels LB, Hollander JE, Apple FS, Cannon C, Nagurney JT, Schreiber D, deFilippi C, Hogan C, Diercks DB, Stein JC, Headden G, Limkakeng J, Anand I, Wu AHB, Papassotiriou J, Hartmann O, Ebmeyer S, Clopton P, Jaffe AS, PeacockWF. Copeptin helps in the early detection of patients with acute myocardial infarction: primary results of the CHOPIN Trial (Copeptin Helps in the early detection Of Patients with acute myocardial INfarction). J Am Coll Cardiol 2013;62: 150-160.
9. Mockel M. Copeptin adds to high-sensitivity troponin T in rapid rule out of acute myocardial infarction. Clin Chem 2012;58:306-307.
10. Ray P, Charpentier S, Chenevier-Gobeaux C, Reichlin T, Twerenbold R, Claessens YE, Jourdain P, Riou B, Mueller C. Combined copeptin and troponin to rule out myocardial infarction in patients with chest pain and a history of coronary artery disease. Am J Emerg Med 2012;30:440-448.
11. Giannitsis E, Kehayova T, Vafaie M, Katus HA. Combined testing of high-sensitivity troponin T and copeptin on presentation at prespecified cutoffs improves rapid rule-out of non-ST-segment elevation myocardial infarction. Clin Chem 2011;57: 1452-1455.
12. Karakas M, Januzzi JL Jr., Meyer J, Lee H, Schlett CL, Truong QA, Rottbauer W, Bamberg F, Dasdemir S, Hoffmann U, KoenigW. Copeptin does not add diagnostic information to high-sensitivity troponin T in low-to intermediate-risk patients with acute chest pain: results from the rule out myocardial infarction by computed tomography (ROMICAT) study. Clin Chem 2011;57:1137-1145.
13. Llorens P, Sanchez M, Herrero P, Martin-Sanchez FJ, Pinera P, Miro O. The utility of copeptin in the emergency department for non-ST-elevation myocardial infarction rapid rule out: COPED-MIRRO study. Eur J Emerg Med 2013 [Epub ahead of print].
14. Eggers KM, Venge P, Lindahl B. High-sensitive cardiac troponin T outperforms novel diagnostic biomarkers in patients with acute chest pain. Clin Chim Acta 2012;413: 1135-1140.
15. Collinson P, Gaze D, Goodacre S. Comparison of contemporary troponin assays with the novel biomarkers, heart fatty acid binding protein and copeptin, for the early confirmation or exclusion of myocardial infarction in patients presenting to the emergency department with chest pain. Heart 2014;100:140-145.
16. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, The Writing Group on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Universal Definition of Myocardial Infarction, Authors/Task Force Members Chairpersons, Thygesen K. Third universal definition of myocardial infarction. Eur Heart J 2012; 33:2551-2567.
17. Manini AF, Gisondi MA, van der Vlugt TM, Schreiber DH. Adverse cardiac events in emergency department patients with chest pain six months after a negative inpatient evaluation for acute coronary syndrome. Acad Emerg Med 2002;9:896-902.
18. Searle J, Shih J, Muller R, Vollert JO, Muller C, Danne O, Datwyler S, Mockel M. The role of myeloperoxidase (MPO) for prognostic evaluation in sensitive cardiac troponin I negative chest pain patients in the emergency department. Eur Heart J Acute Cardiovasc Care 2013;2:203-210.
19. Mockel M, Muller R, Vollert J, Muller C, Danne O, Gareis R, Stork T, Dietz R, Koenig W. Lipoprotein-associated phospholipase A2 for early risk stratification in patients with suspected acute coronary syndrome: a multi-marker approach: the North Wuerttemberg and Berlin Infarction Study-II (NOBIS-II). Clin Res Cardiol 2007;96:604-612.
20. Wilson EB. Probable inference, the law of succession, and statistical inference. J Am Stat Assoc 1927;22:209-212.
21. HammCW, Bassand JP. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2011;32:2999-3054.
22. Keller T, Zeller T, Peetz D, Tzikas S, Roth A, Czyz E, Bickel C, Baldus S,Warnholtz A, Frohlich M, Sinning CR, Eleftheriadis MS, Wild PS, Schnabel RB, Lubos E, Jachmann N, Genth-Zotz S, Post F, Nicaud V, Tiret L, Lackner KJ, Munzel TF, Blankenberg S. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med 2009;361:868-877.
23. Reichlin T, Hochholzer W, Bassetti S, Steuer S, Stelzig C, Hartwiger S, Biedert S, Schaub N, Buerge C, Potocki M, Noveanu M, Breidthardt T, Twerenbold R, Winkler K, Bingisser R, Mueller C. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays. N Engl J Med 2009;361:858-867.
24. Giannitsis E, Becker M, Kurz K, Hess G, Zdunek D, Katus HA. High-sensitivity cardiac troponin T for early prediction of evolving non-ST-segment elevation myocardial infarction in patients with suspected acute coronary syndrome and negative troponin results on admission. Clin Chem 2010;56:642-650.
25. Keller T, Zeller T, Ojeda F, Tzikas S, Lillpopp L, Sinning C, Wild P, Genth-Zotz S, Warnholtz A, Giannitsis E, Mockel M, Bickel C, Peetz D, Lackner K, Baldus S, Munzel T, Blankenberg S. Serial changes in highly sensitive troponin I assay and early diagnosis of myocardial infarction. JAMA 2011;306:2684-2693.
26. Reichlin T, Schindler C, Drexler B, Twerenbold R, Reiter M, Zellweger C, Moehring B, Ziller R, Hoeller R, Rubini GM, Haaf P, Potocki M, Wildi K, Balmelli C, Freese M, Stelzig C, Freidank H, Osswald S, Mueller C. One-hour rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Arch Intern Med 2012;172:1211-1218.
27. Hammarsten O. Small changes in cardiac troponin levels are common in patients with myocardial infarction: diagnostic implications. Conf Pap Med 2013;2013:1-5.
28. DissmannW, de Ridder M. The soft science of German cardiology. Lancet 2002;359: 2027-2029.